Cargando…
Importance of immunoglobulin therapy for COVID-19 patients with lymphocytopenia
BACKGROUND: The global coronavirus disease 2019 (COVID-19) was announced as pandemic by the World Health Organization (WHO). With the increased number of infected and dead victims daily all over the world, it becomes necessary to stop or overcome its rapid spread. Main body Although the production o...
Autor principal: | Nabih, Heba K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897881/ https://www.ncbi.nlm.nih.gov/pubmed/33642851 http://dx.doi.org/10.1186/s42269-021-00502-4 |
Ejemplares similares
-
Lymphocytopenia and Radiotherapy Treatment Volumes in the Time of COVID-19
por: Joseph, N., et al.
Publicado: (2020) -
Idiopathic CD4 Lymphocytopenia: Current Insights
por: Vijayakumar, Saravanakumari, et al.
Publicado: (2020) -
Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients
por: Mo, Yufei, et al.
Publicado: (2022) -
Lymphocytosis, Lymphocytopenia, Hypergammaglobulinemia, and Hypogammaglobulinemia
por: Mims, Martha P.
Publicado: (2018) -
Effect of thymalfasin (Thymosin-α-1) on reversing lymphocytopenia among patients with COVID-19
por: Benitez, Gregorio, et al.
Publicado: (2023)